Compare NRXP & SPEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRXP | SPEG |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 158.7M |
| IPO Year | 2017 | 2025 |
| Metric | NRXP | SPEG |
|---|---|---|
| Price | $3.35 | $10.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 635.1K | 18.2K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,225,000.00 | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.95 |
| 52 Week High | $5.06 | $11.03 |
| Indicator | NRXP | SPEG |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 58.52 |
| Support Level | $3.09 | $10.26 |
| Resistance Level | $3.50 | $10.39 |
| Average True Range (ATR) | 0.14 | 0.01 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 47.19 | 66.67 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Silver Pegasus Acquisition Corp is a blank check company.